# Rivastigmine Tartrate

NDC: 62332-063
Generic name: Rivastigmine Tartrate
Labeler / Manufacturer: Alembic Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20220612

FDA application: ANDA091689

## Active ingredients

- RIVASTIGMINE TARTRATE: 1.5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"62332-063"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=62332-063
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0044f1d7-613c-4611-8481-13032c8cb390